India's Biological E. to produce J&J COVID-19 vaccine

India's Biological E. will produce the Johnson & Johnson (JNJ.N) COVID-19 vaccine alongside its own candidate, its managing director told Reuters on Tuesday, which could boost the country's overall supplies amid a shortage.
"The infrastructure and plants are completely separate for both the products and we will be producing both independent of each other," Mahima Datla said in a text message, declining to give any timeline or other details.